SE0202465D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE0202465D0 SE0202465D0 SE0202465A SE0202465A SE0202465D0 SE 0202465 D0 SE0202465 D0 SE 0202465D0 SE 0202465 A SE0202465 A SE 0202465A SE 0202465 A SE0202465 A SE 0202465A SE 0202465 D0 SE0202465 D0 SE 0202465D0
- Authority
- SE
- Sweden
- Prior art keywords
- new compounds
- formula
- receptor agonists
- acetylcholine receptor
- nicotinic acetylcholine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202465A SE0202465D0 (sv) | 2002-08-14 | 2002-08-14 | New compounds |
BR0313233-1A BR0313233A (pt) | 2002-08-14 | 2003-08-13 | Composto, uso do mesmo, método de tratamento ou profilaxia de doenças, e, composição farmacêutica |
CNB038192578A CN100436453C (zh) | 2002-08-14 | 2003-08-13 | 作为烟碱性乙酰胆碱激动剂的芳基取代的二氮杂双环烷烃 |
AT03788213T ATE430152T1 (de) | 2002-08-14 | 2003-08-13 | Aryl-substituierte diazabicycloalkane als nikotinische acetylcholinagonisten |
KR1020057002266A KR20060005334A (ko) | 2002-08-14 | 2003-08-13 | 니코틴성 아세틸콜린 아고니스트로서의 아릴 치환된디아자비시클로알칸 |
PCT/SE2003/001276 WO2004016616A1 (en) | 2002-08-14 | 2003-08-13 | Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
AU2003248590A AU2003248590B2 (en) | 2002-08-14 | 2003-08-13 | Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
MXPA05001584A MXPA05001584A (es) | 2002-08-14 | 2003-08-13 | Diazabiciloalcanos sustituidos con arilo como agonistas de acetilcolina nicotinicos. |
EP03788213A EP1539764B1 (en) | 2002-08-14 | 2003-08-13 | Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
JP2004529001A JP2005539030A (ja) | 2002-08-14 | 2003-08-13 | ニコチン性アセチルコリン作用剤としてのアリール置換ジアザビシクロアルカン |
US10/524,482 US20060052368A1 (en) | 2002-08-14 | 2003-08-13 | Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
DE60327441T DE60327441D1 (de) | 2002-08-14 | 2003-08-13 | Aryl-substituierte diazabicycloalkane als nikotinische acetylcholinagonisten |
CA002493246A CA2493246A1 (en) | 2002-08-14 | 2003-08-13 | Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
IL16642505A IL166425A0 (en) | 2002-08-14 | 2005-01-20 | Aryl-substituted diazabicyclkanes as nicotinic acetylcholine agonists |
ZA200501227A ZA200501227B (en) | 2002-08-14 | 2005-02-10 | Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
NO20051260A NO20051260L (no) | 2002-08-14 | 2005-03-11 | Arylsubstituerte diazabicykloalkaner som nikotinacetylcholinagonister |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202465A SE0202465D0 (sv) | 2002-08-14 | 2002-08-14 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0202465D0 true SE0202465D0 (sv) | 2002-08-14 |
Family
ID=20288753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0202465A SE0202465D0 (sv) | 2002-08-14 | 2002-08-14 | New compounds |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060052368A1 (sv) |
EP (1) | EP1539764B1 (sv) |
JP (1) | JP2005539030A (sv) |
KR (1) | KR20060005334A (sv) |
CN (1) | CN100436453C (sv) |
AT (1) | ATE430152T1 (sv) |
AU (1) | AU2003248590B2 (sv) |
BR (1) | BR0313233A (sv) |
CA (1) | CA2493246A1 (sv) |
DE (1) | DE60327441D1 (sv) |
IL (1) | IL166425A0 (sv) |
MX (1) | MXPA05001584A (sv) |
NO (1) | NO20051260L (sv) |
SE (1) | SE0202465D0 (sv) |
WO (1) | WO2004016616A1 (sv) |
ZA (1) | ZA200501227B (sv) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
SE0202430D0 (sv) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New Compounds |
EP1543000B1 (en) | 2002-09-25 | 2013-03-06 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
US7456171B2 (en) * | 2002-10-08 | 2008-11-25 | Sanofi-Aventis | 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof |
DK1578422T3 (da) | 2002-12-20 | 2007-07-02 | Niconovum Ab | Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale |
AU2004215658B2 (en) * | 2003-02-27 | 2010-06-24 | Neurosearch A/S | Novel diazabicyclic aryl derivatives |
CN100445285C (zh) * | 2003-12-22 | 2008-12-24 | 阿斯利康(瑞典)有限公司 | 烟碱性乙酰胆碱受体配体 |
TW200529860A (en) * | 2003-12-22 | 2005-09-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
CA2550689A1 (en) | 2003-12-22 | 2005-07-14 | Memory Pharmaceuticals Corporation | Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
FR2865208B1 (fr) * | 2004-01-16 | 2009-01-16 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique |
EP1713810B1 (en) * | 2004-02-04 | 2010-12-29 | NeuroSearch A/S | Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands |
EP1725236A4 (en) * | 2004-03-11 | 2009-05-13 | Glaxo Group Ltd | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS |
JP4995075B2 (ja) | 2004-03-25 | 2012-08-08 | メモリー・ファーマシューティカルズ・コーポレイション | インダゾール、ベンゾチアゾール、ベンゾイソチアゾール、ベンズイソキサゾール、ならびにそれらの調製および使用 |
ATE487716T1 (de) | 2004-04-22 | 2010-11-15 | Memory Pharm Corp | Indole, 1h-indazole, 1,2-benzisoxazole, 1,2- benzoisothiazole, deren herstellung und verwendungen |
BRPI0510212A (pt) * | 2004-05-07 | 2007-10-16 | Memory Pharm Corp | 1h-indazóis, benzotiazóis, 1,2 - benzoisoxazóis, 1,2-benzoisotiazóis, e cromonas e a preparação e usos dos mesmos |
US7612074B2 (en) | 2004-11-30 | 2009-11-03 | Neurosearch A/S | Diazabicyclic aryl derivatives as cholinergy ligands |
WO2006069097A2 (en) | 2004-12-22 | 2006-06-29 | Memory Pharmaceuticals Corporation | Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
KR20080067339A (ko) * | 2005-11-09 | 2008-07-18 | 메모리 파마슈티칼스 코포레이션 | 1h-인다졸, 벤조티아졸, 1,2-벤조이속사졸,1,2-벤조이소티아졸, 및 크로몬 및 그들의 제조법 및 용도 |
EP1987032A1 (en) | 2006-02-14 | 2008-11-05 | NeuroSearch A/S | 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists |
CA2646942C (en) | 2006-03-16 | 2014-07-29 | Niconovum Ab | Improved snuff composition |
TWI454262B (zh) * | 2006-11-02 | 2014-10-01 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
JP2011513421A (ja) * | 2008-03-05 | 2011-04-28 | ターガセプト,インコーポレイテッド | サブタイプ選択的なジアザビシクロアルカンのアミド |
EA201001889A1 (ru) | 2008-06-20 | 2011-08-30 | Астразенека Аб | Производные дибензотиазепина и их применение |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
WO2011146511A1 (en) | 2010-05-17 | 2011-11-24 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
CA2822400C (en) * | 2010-12-22 | 2019-02-12 | Tosoh Corporation | Novel cyclic amine compound and process for producing polyurethane resin by using it |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
WO2013098416A2 (fr) * | 2011-12-30 | 2013-07-04 | Ecole Nationale Superieure De Chimie De Clermont Ferrand | Composes anti-douleur |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
US8609162B2 (en) | 2012-10-04 | 2013-12-17 | Invivo Beverages Llc | Integrated neuromodulation system for mood enhancement of a living human subject |
WO2014122474A1 (en) | 2013-02-07 | 2014-08-14 | Takeda Pharmaceutical Company Limited | Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists |
EP3010900B1 (en) | 2013-06-21 | 2018-01-03 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
WO2019005874A1 (en) | 2017-06-26 | 2019-01-03 | The Trustees Of Columbia University In The City Of New York | CHOLINERGIC AGONISM FOR THE TREATMENT OF PANCREATIC CANCER |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3281423A (en) * | 1964-02-03 | 1966-10-25 | Merck & Co Inc | 1, 3-ethanopiperazines and process |
US4895943A (en) * | 1988-10-25 | 1990-01-23 | Pfizer Inc. | Preparation of 1,4-diazabicyclo(3.2.2)nonane |
US5679673A (en) * | 1992-09-24 | 1997-10-21 | The United States Of America, Represented By The Department Of Health And Human Services | Aralkyl bridged diazabicycloalkane derivatives for CNS disorders |
FR2791678B1 (fr) * | 1999-03-30 | 2001-05-04 | Synthelabo | Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique |
FR2809730B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique |
FR2809732B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE |
FR2809731B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique |
US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
SE0202430D0 (sv) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New Compounds |
AU2004215658B2 (en) * | 2003-02-27 | 2010-06-24 | Neurosearch A/S | Novel diazabicyclic aryl derivatives |
TW200529860A (en) * | 2003-12-22 | 2005-09-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
CN100445285C (zh) * | 2003-12-22 | 2008-12-24 | 阿斯利康(瑞典)有限公司 | 烟碱性乙酰胆碱受体配体 |
-
2002
- 2002-08-14 SE SE0202465A patent/SE0202465D0/sv unknown
-
2003
- 2003-08-13 EP EP03788213A patent/EP1539764B1/en not_active Expired - Lifetime
- 2003-08-13 BR BR0313233-1A patent/BR0313233A/pt not_active IP Right Cessation
- 2003-08-13 AU AU2003248590A patent/AU2003248590B2/en not_active Expired - Fee Related
- 2003-08-13 JP JP2004529001A patent/JP2005539030A/ja active Pending
- 2003-08-13 AT AT03788213T patent/ATE430152T1/de not_active IP Right Cessation
- 2003-08-13 WO PCT/SE2003/001276 patent/WO2004016616A1/en active Application Filing
- 2003-08-13 CA CA002493246A patent/CA2493246A1/en not_active Abandoned
- 2003-08-13 US US10/524,482 patent/US20060052368A1/en not_active Abandoned
- 2003-08-13 KR KR1020057002266A patent/KR20060005334A/ko not_active Application Discontinuation
- 2003-08-13 CN CNB038192578A patent/CN100436453C/zh not_active Expired - Fee Related
- 2003-08-13 MX MXPA05001584A patent/MXPA05001584A/es unknown
- 2003-08-13 DE DE60327441T patent/DE60327441D1/de not_active Expired - Fee Related
-
2005
- 2005-01-20 IL IL16642505A patent/IL166425A0/xx unknown
- 2005-02-10 ZA ZA200501227A patent/ZA200501227B/en unknown
- 2005-03-11 NO NO20051260A patent/NO20051260L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL166425A0 (en) | 2006-01-15 |
AU2003248590A1 (en) | 2004-03-03 |
ZA200501227B (en) | 2006-07-26 |
MXPA05001584A (es) | 2005-04-25 |
ATE430152T1 (de) | 2009-05-15 |
WO2004016616A1 (en) | 2004-02-26 |
JP2005539030A (ja) | 2005-12-22 |
US20060052368A1 (en) | 2006-03-09 |
EP1539764B1 (en) | 2009-04-29 |
CN1675215A (zh) | 2005-09-28 |
KR20060005334A (ko) | 2006-01-17 |
EP1539764A1 (en) | 2005-06-15 |
CA2493246A1 (en) | 2004-02-26 |
AU2003248590B2 (en) | 2008-03-20 |
NO20051260L (no) | 2005-05-10 |
BR0313233A (pt) | 2005-06-14 |
DE60327441D1 (de) | 2009-06-10 |
CN100436453C (zh) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0202465D0 (sv) | New compounds | |
CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
DE60309848D1 (de) | Purinderivate als kinaseinhibitoren | |
DK1761520T3 (da) | Kinaseinhibitorer | |
SE0000540D0 (sv) | New compounds | |
DE60335359D1 (de) | Phthalazinonderivate | |
ATE360627T1 (de) | Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren | |
NO20076306L (no) | Bicykliske derivater som modulatorer av ionekanaler | |
UY29612A1 (es) | Compuestos quimicos ii | |
CY1113648T1 (el) | Παραγωγα πυριδινονης για θεραπεια αθηροσκληρωσης | |
EA200601391A1 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
CR20120421A (es) | Compuestos de aminohetetoarilo o sustituidos con pirazol como inhibidores de proteina quinasa | |
ATE490253T1 (de) | Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
NO20031001L (no) | Polyarylkarboksamider nyttige som lipidsenkende midler | |
ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
CY1109680T1 (el) | Υποκατεστημενες πυριδινονες ως ρυθμιστες της ρ38 μαρ κινασης | |
ATE422198T1 (de) | Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten | |
ATE302775T1 (de) | Carbolinderivate | |
DOP2005000010A (es) | Inhibidores de quinasa | |
ATE384039T1 (de) | Indanderivate als muscarinrezeptoragonisten | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
CY1107156T1 (el) | Νεα μεθοδος συνθεσης του (7-μεθοξυ-3,4-διυδρο-1-ναφθαλινυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης | |
ATE346067T1 (de) | Carbolinderivate | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 |